Skip to main content
Equibles

PROFUND ADVISORS LLC

Position in CGEM — Cullinan Therapeutics, Inc.

CIK 1129919 BETHESDA, MD
Back to CGEM Full portfolio

Position in CGEM

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$608,268
+$164,192 QoQ
Shares Held
33,403
+6.9% QoQ
Ownership
0.052%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#90
of 183 holders
Holding Since
Mar 2024
8 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CGEM Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

PROFUND ADVISORS LLC holds $165,155,882 across 170 Biotechnology names. CGEM ranks #85 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 23,398 $11,622,488
2 REGN
Regeneron Pharmaceuticals, Inc.
 10,444 $6,512,251
3 ALNY
Alnylam Pharmaceuticals, Inc.
 13,814 $4,158,428
4 MRNA
Moderna, Inc.
 33,142 $2,320,934
5 APGE
Apogee Therapeutics, Inc.
 17,163 $2,278,044
6 CYTK
Cytokinetics Inc
 25,572 $2,178,478
7 TWST
Twist Bioscience Corp
 21,095 $2,170,253
8 KRYS
Krystal Biotech, Inc.
 5,770 $2,144,535

All Filings in CGEM

Export CSV
8 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $608,268 33,403
2026-03-31 $444,076 31,251
2025-12-31 $240,968 23,282
2025-03-31 $89,674 11,846
2024-12-31 $214,599 17,619
2024-09-30 $381,203 22,772
2024-06-30 $337,498 19,352
2024-03-31 $260,081 15,263